Heparin market analysis | Coherent Market Insights

1
Coherent Marketing Insights

• Market Research Business Consulting Services

• https//www.coherentmarketinsights.com/

• Covid-19 Impact Tracker

2

• HEPARIN MARKET ANALYSIS
• Heparin Market, by Product Type (Unfractionated
  Heparin (UH), Low Molecular Weight Heparin
  (LMWH), and Ultra-low Molecular Weight Heparin
  (ULMW)), by Dosage Form (Injection, and
  Solutions), and by Region (North America, Latin
  America, Europe, Asia Pacific, Middle East, and
  Africa) - Size, Share, Outlook, and Opportunity
  Analysis, 2018 - 2026

3

• Heparin is used to prevent or treat certain blood
  vessel, heart, and lung conditions. It is also
  used in blood transfusion, blood samplings during
  prophylaxis treatment, and for treatment of blood
  clotting disorders Heparin may be used to
  diagnose and treat a serious blood condition
  called disseminated intravascular coagulation.
  Heparin is sometimes used alone or in combination
  with aspirin to prevent pregnancy loss and other
  problems.
• The global heparin market size was valued at US
  9.4 billion in 2017 and is expected to witness a
  CAGR of 5.1 over the forecast period (2018
  2026).

4

• Global Heparin Market Value (US Bn) Y-o-Y
  Growth ()

5

• Increasing incidences of coronary heart disease,
  pulmonary embolism, and deep vein thrombosis is
  expected to drive growth of the heparin market
• Heparin is widely used clinically for dialysis,
  deep vein thrombosis (DVT) treatment, and most
  cardiac surgeries. It is also used to prevent
  blood clotting during open-heart surgery, kidney
  dialysis, bypass surgery, and blood transfusions.
  Kidney dialysis procedure is increasing with
  rising chronic kidney disease, worldwide. For
  instance, according to Kidney Care UK 2016
  report, about 3 million people in the U.K. are
  suffering from chronic kidney disease (CKD).
• Furthermore, increasing number of surgeries and
  rising prevalence of diseases such as deep vein
  thrombosis and coronary heart disease, are
  fueling demand for heparin, eventually driving
  growth of the heparin market, during the forecast
  period. According to the American Heart
  Association 2018 report, coronary heart disease
  accounts for 1 in 7 deaths in the U.S., killing
  over 366,800 people every year. As per the same
  source, the overall prevalence for myocardial
  infarction (MI) in the U.S. is about 7.9 million,
  or 3 percent in U.S. adults.

6
Heparin Market Restraints

• Side effects associated with the use of heparin
  are the major restraining factors of the market.
  The main side effect of heparin is bleeding.
  Heparin can cause spontaneous bleeding from
  several places in the body including open wounds
  or surgical sites, intestines and stomach,
  ovaries and uterus, and mouth and gums. Another
  serious side effect of heparin is a condition
  known as heparin-induced thrombocytopenia (HIT)
  in which heparin induces the body's immune system
  to develop antibodies against its own platelets,
  causing risk of bleeding due to reduction in
  platelets.
• Heparin Market - Regional InsightsOn the basis
  of region, the global heparin market is segmented
  into North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa. Europe heparin
  market is expected to generate significant
  revenue share during the forecast period, owing
  to growing geriatric population and rising
  prevalence of long-term survivors of acute
  myocardial infarction (AMI). Survivors of AMI are
  at high risk of a recurrent myocardial
  infarction, as well as other manifestations of
  cardiovascular disease such as stroke. According
  to Lancet journal, 2017 report, acute myocardial
  infarction is the leading cause of hospital
  admissions and mortality in the UK and across the
  world.

7
Global Heparin Market Share (), By Region 2017

8
Heparin Market - Competitive Landscape

• Key players operating in the global heparin
  market include Anselm Pharmaceuticals, Baxter
  International Inc., B. Braun Melsungen AG,
  Bristol-Myers Squibb Co., Dr. Reddys
  Laboratories Ltd., Fresenius SE Co. KGaA, Leap
  Labchem Co., LEO Pharma A/S, Pfizer, Inc., Sanofi
  S.A., Syntex S.A., Teva Pharmaceutical Industries
  Ltd., and United Biotech (P) Ltd.

9

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Referance https//www.coherentmarketinsights.com/
  market-insight/heparin-market-2602

10
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions. We are headquartered
  in India, having office at global financial
  capital in the U.S. Our client base includes
  players from across all business verticals in
  over 150 countries worldwide.
• What We ProvideCustomized Market Research
  AnalysisIndustry Analysis ServicesBusiness
  Consulting ServicesLong Term Engagement
  ModelCountry Specific Analysis

11
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt. LTD.Coherent
  Market Insights 1001 4th Ave, 3200 Seattle, WA
  98154, U.S.Phone [phone]
• Email sales_at_coherentmarketinsights.com

12
Thank You

• Kindly Follow CMI Social Media Profiles for the
  latest Company Updates.
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/